Literature DB >> 23353733

A flexible approach to 1,4-di-substituted 2-aminoimidazoles that inhibit and disperse biofilms and potentiate the effects of β-lactams against multi-drug resistant bacteria.

Robert E Furlani1, Andrew A Yeagley, Christian Melander.   

Abstract

The pyrrole-imidazole alkaloids are a 2-aminoimidazoles containing family of natural products that possess anti-biofilm activity. A library of 1,4-di-substituted 2-aminoimidazole/triazoles (2-AITs) was synthesized, and its anti-biofilm activity as well as oxacillin resensitization efficacy toward methicillin resistant Staphylococcus aureus (MRSA) was investigated. These 2-AITs were found to inhibit biofilm formation by MRSA with low micromolar IC50 values. Additionally, the most active compound acted synergistically with oxacillin against MRSA lowering the minimum inhibitory concentration (MIC) 4-fold.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23353733     DOI: 10.1016/j.ejmech.2012.12.005

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  13 in total

1.  Teaching old drugs new tricks: Addressing resistance in Francisella.

Authors:  Erik A Feldmann; John Cavanagh
Journal:  Virulence       Date:  2015       Impact factor: 5.882

2.  Meridianin D Analogues Display Antibiofilm Activity against MRSA and Increase Colistin Efficacy in Gram-Negative Bacteria.

Authors:  William M Huggins; William T Barker; James T Baker; Nicholas A Hahn; Roberta J Melander; Christian Melander
Journal:  ACS Med Chem Lett       Date:  2018-05-25       Impact factor: 4.345

3.  Anti-biofilm activity and synergism of novel thiazole compounds with glycopeptide antibiotics against multidrug-resistant staphylococci.

Authors:  Haroon Mohammad; Abdelrahman S Mayhoub; Mark Cushman; Mohamed N Seleem
Journal:  J Antibiot (Tokyo)       Date:  2014-10-15       Impact factor: 2.649

4.  Evaluation of ethyl N-(2-phenethyl) carbamate analogues as biofilm inhibitors of methicillin resistant Staphylococcus aureus.

Authors:  Matthew D Stephens; Nisakorn Yodsanit; Christian Melander
Journal:  Org Biomol Chem       Date:  2016-07-12       Impact factor: 3.876

5.  Second Generation Modifiers of Colistin Resistance Show Enhanced Activity and Lower Inherent Toxicity.

Authors:  Christopher M Brackett; Robert E Furlani; Ryan G Anderson; Aparna Krishnamurthy; Roberta J Melander; Samuel M Moskowitz; Robert K Ernst; Christian Melander
Journal:  Tetrahedron       Date:  2016-06-23       Impact factor: 2.457

6.  Small molecule inhibitors of AI-2 signaling in bacteria: state-of-the-art and future perspectives for anti-quorum sensing agents.

Authors:  Min Guo; Sonja Gamby; Yue Zheng; Herman O Sintim
Journal:  Int J Mol Sci       Date:  2013-08-29       Impact factor: 5.923

Review 7.  Elimination of Bloodstream Infections Associated with Candida albicans Biofilm in Intravascular Catheters.

Authors:  Freshta Akbari; Birthe Veno Kjellerup
Journal:  Pathogens       Date:  2015-06-29

8.  Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius.

Authors:  Haroon Mohammad; P V Narasimha Reddy; Dennis Monteleone; Abdelrahman S Mayhoub; Mark Cushman; G Kenitra Hammac; Mohamed N Seleem
Journal:  PLoS One       Date:  2015-06-18       Impact factor: 3.240

9.  Development of benzo[1,4]oxazines as biofilm inhibitors and dispersal agents against Vibrio cholerae.

Authors:  Christopher J A Warner; Andrew T Cheng; Fitnat H Yildiz; Roger G Linington
Journal:  Chem Commun (Camb)       Date:  2015-01-25       Impact factor: 6.222

10.  Bacteriological profiling of diphenylureas as a novel class of antibiotics against methicillin-resistant Staphylococcus aureus.

Authors:  Haroon Mohammad; Waleed Younis; Hany G Ezzat; Christine E Peters; Ahmed AbdelKhalek; Bruce Cooper; Kit Pogliano; Joe Pogliano; Abdelrahman S Mayhoub; Mohamed N Seleem
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.